Literature DB >> 3799062

Antigenic variation among human strains of influenza C virus detected with monoclonal antibodies to gp88 glycoprotein.

K Sugawara, H Nishimura, F Kitame, K Nakamura.   

Abstract

Antigenic variation among influenza C virus strains was investigated with monoclonal antibodies against gp88 glycoprotein. Seven monoclonal antibodies obtained were tentatively classified into two groups, A and B. The group A antibodies had hemagglutination inhibition (HI), hemolysis inhibition and neutralization activities whereas the group B antibodies possessed none of them. A comparison of antigenicity among 15 human strains with these antibodies in radioimmunoprecipitation and HI tests showed that the regions recognized by the group A antibodies undergo considerable changes, whereas those by group B are conserved among the strains.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3799062     DOI: 10.1016/0168-1702(86)90054-7

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  17 in total

1.  Protective effect of serum antibody on respiratory infection of influenza C virus in rats.

Authors:  K Takiguchi; K Sugawara; S Hongo; H Nishimura; F Kitame; K Nakamura
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Characterization of a second protein (CM2) encoded by RNA segment 6 of influenza C virus.

Authors:  S Hongo; K Sugawara; Y Muraki; F Kitame; K Nakamura
Journal:  J Virol       Date:  1997-04       Impact factor: 5.103

3.  Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins.

Authors:  J Zhang; A Pekosz; R A Lamb
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

4.  Intrinsic temperature sensitivity of influenza C virus hemagglutinin-esterase-fusion protein.

Authors:  Emi Takashita; Yasushi Muraki; Kanetsu Sugawara; Hironobu Asao; Hidekazu Nishimura; Koji Suzuki; Takashi Tsuji; Seiji Hongo; Yoshiro Ohara; Yoshihiro Ohara; Yoshihiro Kawaoka; Makoto Ozawa; Yoko Matsuzaki
Journal:  J Virol       Date:  2012-09-26       Impact factor: 5.103

5.  Cell surface expression of biologically active influenza C virus HEF glycoprotein expressed from cDNA.

Authors:  A Pekosz; R A Lamb
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

6.  Genetic Lineage and Reassortment of Influenza C Viruses Circulating between 1947 and 2014.

Authors:  Yoko Matsuzaki; Kanetsu Sugawara; Yuki Furuse; Yoshitaka Shimotai; Seiji Hongo; Hitoshi Oshitani; Katsumi Mizuta; Hidekazu Nishimura
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

7.  Influenza C virus NS1 protein upregulates the splicing of viral mRNAs.

Authors:  Yasushi Muraki; Takatoshi Furukawa; Yoshihiko Kohno; Yoko Matsuzaki; Emi Takashita; Kanetsu Sugawara; Seiji Hongo
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

8.  Effect of the addition of oligosaccharides on the biological activities and antigenicity of influenza A/H3N2 virus hemagglutinin.

Authors:  Yasuhiro Abe; Emi Takashita; Kanetsu Sugawara; Yoko Matsuzaki; Yasushi Muraki; Seiji Hongo
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

9.  Influenza C virus CM2 protein is produced from a 374-amino-acid protein (P42) by signal peptidase cleavage.

Authors:  S Hongo; K Sugawara; Y Muraki; Y Matsuzaki; E Takashita; F Kitame; K Nakamura
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

10.  Antigenic and genetic analyses of eight influenza C strains isolated in various areas of Japan during 1985-9.

Authors:  S Ohyama; K Adachi; K Sugawara; S Hongo; H Nishimura; F Kitame; K Nakamura
Journal:  Epidemiol Infect       Date:  1992-04       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.